Latest Intelligence

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
NewsWire
NewsWire

MCB Finance reports profit for Q3

MCB Finance Group plc, a consumer finance company, has reported that profit for the third quarter ended September 30, 2014 was E561,038, or E0.0298 per diluted share, compared to a loss of E1.49 million, or E0.0844 loss per diluted share, for the same quarter ended September 30, 2013.

Published By MarketLine
17 Dec 2014
NewsWire
NewsWire

Evans Bank appoints four new assistant vice presidents

Evans Bank, N.A. has announced the appointment of Brian Dauksha, Kimberley Fix, John Jimenez, and Kimberly Stehlar as assistant vice presidents.

Published By MarketLine
17 Dec 2014
NewsWire
NewsWire

Novadaq receives US patent for intra-operative angiography technology

Novadaq Technologies Inc., a developer of fluorescence imaging solutions, has received a US patent entitled, method and apparatus for performing intra-operative angiography.

Published By MarketLine
17 Dec 2014
NewsWire
NewsWire

Vertex appoints EVP of global research and chief scientific officer

Vertex Pharmaceuticals Incorporated, a biotechnology company, has appointed David Altshuler as executive vice president, or EVP, global research and chief scientific officer.

Published By MarketLine
17 Dec 2014
NewsWire
NewsWire

China Investment Development H1 loss increases

China Investment Development Limited has reported that loss attributable to owners of the company for the six months ended September 30, 2014 was HK$83.33 million, or a loss of 0.10 cents per share, compared to a loss attributable owners of the company of HK$6.43 million, or a loss of 0.99 cents per share, for the same period ended September 30, 2013.

Published By MarketLine
17 Dec 2014
NewsWire
NewsWire

BioCryst doses first subject in Phase I viral hemorrhagic fever trial

BioCryst Pharmaceuticals, Inc., a biotechnology company, has dosed the first subject in a randomized, placebo-controlled Phase I clinical trial to evaluate intramuscular, or I.M., administration of BCX4430, which is developed as a treatment for hemorrhagic fever viruses, including Ebola virus and Marburg virus disease, in healthy volunteers.

Published By MarketLine
17 Dec 2014
NewsWire
NewsWire

Sixdots launches new mobile payment app

Sixdots, the brand name of Belgian Mobile Wallet SA/NV, has launched its new mobile payment app in the App Store and in Google Play.

Published By MarketLine
17 Dec 2014
NewsWire
NewsWire

DXS International receives contract for GP Systems of Choice Lot 2

DXS International Plc, a developer of clinical decision support systems for healthcare professionals, has received a contract for GP Systems of Choice, or GPSoC, Lot 2 to provide additional GP IT Services.

Published By MarketLine
17 Dec 2014
NewsWire
NewsWire

WuXi PharmaTech to open offices in Boston and San Francisco

WuXi PharmaTech, a biotechnology and medical device R&D outsourcing company, has announced the opening of offices in Boston and San Francisco in early 2015.

Published By MarketLine
17 Dec 2014
NewsWire
NewsWire

Philips and Nintendo settle patent disputes and sign license agreement

Royal Philips, a health and well-being company, has settled patent disputes and has signed a patent license agreement with Nintendo Co., Ltd., a developer of entertainment products.

Published By MarketLine
17 Dec 2014

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.